Canada Pension Plan Investment Board Replimune Group, Inc. Transaction History

Canada Pension Plan Investment Board

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$6.75 - $16.18 $2.15 Million - $5.16 Million	319,000 New	319,000 $2.69 Million
Q2 2021 Aug 16, 2021	SELL	$28.5 - $39.37 $1.71 Million - $2.36 Million	-60,000 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$30.22 - $45.57 $1.81 Million - $2.73 Million	60,000 New	60,000 $1.83 Million
Q3 2020 Nov 12, 2020	SELL	$18.85 - $27.0 $1.13 Million - $1.62 Million	-60,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$9.76 - $25.95 $585,600 - $1.56 Million	60,000 New	60,000 $1.49 Million
Q1 2020 May 13, 2020	SELL	$8.9 - $19.08 $267,000 - $572,400	-30,000 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$11.61 - $17.21 $348,300 - $516,300	30,000 New	30,000 $431,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.